128 related articles for article (PubMed ID: 4114489)
1. [Liver function and glucose tolerance during treatment with the oral contraceptive ovosiston].
Heller H
Dtsch Gesundheitsw; 1972 Jun; 27(22):1035-8. PubMed ID: 4114489
[No Abstract] [Full Text] [Related]
2. [Drug-induced liver damage following use of the oral contraceptive Femigen].
Kwaśniewska W; Raczyńska A
Patol Pol; 1974; 25(1):101-6. PubMed ID: 4133325
[No Abstract] [Full Text] [Related]
3. [Modification of serum lipids and glucose tolerance by sequential Ovosiston and Minisiston].
Vesper VB; Feustel S
Zentralbl Gynakol; 1988; 110(4):241-5. PubMed ID: 2453102
[TBL] [Abstract][Full Text] [Related]
4. [Menstruation disorders due to Ovosiston medication].
Kühndel K; Ebeling K; Rothe K
Dtsch Gesundheitsw; 1971 Jan; 26(3):109-13. PubMed ID: 4106361
[No Abstract] [Full Text] [Related]
5. Severe endogenous hypertriglyceridemia during treatment with estrogen and oral contraceptives.
Zorrilla E; Hulse M; Hernandez A; Gershberg H
J Clin Endocrinol Metab; 1968 Dec; 28(12):1793-6. PubMed ID: 4177383
[No Abstract] [Full Text] [Related]
6. ["1st experiences with Ovosiston in a new dosage--a comparative study of oral contraception with 'old' and 'new' Ovosiston". "Experiences with Ovosiston in contraception. II. " Reply to the viewpoint of D. Kühne].
Zwahr C
Dtsch Gesundheitsw; 1970 Nov; 25(47):2247-50. PubMed ID: 4099776
[No Abstract] [Full Text] [Related]
7. [Intrahepatic cholestasis in hormonal contraception--a case with a difficult and expensive differential diagnosis].
Böhme HH; Otto HJ
Zentralbl Gynakol; 1985; 107(5):311-2. PubMed ID: 2581395
[TBL] [Abstract][Full Text] [Related]
8. [Cholestatic icterus after intake of ovulation inhibitors].
Pansold E; Fischer I; Pfeifer K
Dtsch Gesundheitsw; 1974 Mar; 29(10):470-5. PubMed ID: 4142434
[TBL] [Abstract][Full Text] [Related]
9. Insulin and glucose studies after one year of treatment with a sequential-type oral contraceptive.
Spellacy WN; Buhi WC; Bendel RP
Obstet Gynecol; 1969 Jun; 33(6):800-4. PubMed ID: 4181554
[TBL] [Abstract][Full Text] [Related]
10. [Experiences in ambulatory treatment of female diabetics with oral contraceptive agent, Ovosiston].
Steindel E; Mohnike A; Langreck G
Z Arztl Fortbild (Jena); 1971 Feb; 65(3):159-61. PubMed ID: 4102493
[No Abstract] [Full Text] [Related]
11. [Raynaud-like clinical picture during the treatment with an oral contraceptive].
Ebert H
Dtsch Gesundheitsw; 1970 Aug; 25(35):1642-3. PubMed ID: 4099005
[No Abstract] [Full Text] [Related]
12. [Sequenz-Ovosiston as a contraceptive agent].
Zwahr C
Zentralbl Gynakol; 1972 Dec; 94(49):1722-5. PubMed ID: 4119508
[No Abstract] [Full Text] [Related]
13. [Amenorrhea-galactorrhea following the use of ovosiston].
Kosowski I; Stojanow G; Iliewa W
Zentralbl Gynakol; 1973 Jun; 95(25):851-4. PubMed ID: 4126137
[No Abstract] [Full Text] [Related]
14. [Experience with Ovosiston for contraception. II].
Geschke H
Dtsch Gesundheitsw; 1970 Feb; 25(5):201-6. PubMed ID: 4192921
[No Abstract] [Full Text] [Related]
15. Some apparently common problems in patients receiving contraceptive pills.
Ball P
Nebr State Med J; 1968 Sep; 53(9):428-32. PubMed ID: 4176717
[No Abstract] [Full Text] [Related]
16. Oral contraceptives and carbohydrate metabolism.
Di Paola G; Puchulu F; Robin M; Nicholson R; Marti M
Am J Obstet Gynecol; 1968 May; 101(2):206-16. PubMed ID: 4172445
[No Abstract] [Full Text] [Related]
17. [Experiences with Ovosiston in marital and sexual counseling in a district hospital in the period Jan. 1, 1967-Dec. 31, 1968].
Keil G
Z Arztl Fortbild (Jena); 1970 May; 64(10):500-1. PubMed ID: 4106558
[No Abstract] [Full Text] [Related]
18. Glucose, insulin, and growth hormone studies in long-term users of oral contraceptives.
Spellacy WN; Buhi WC; Spellacy CE; Moses LE; Goldzieher JW
Am J Obstet Gynecol; 1970 Jan; 106(2):173-82. PubMed ID: 4188445
[No Abstract] [Full Text] [Related]
19. [Experiences with Ovosiston in a new dosage form].
Zwahr C
Dtsch Gesundheitsw; 1970 Apr; 25(14):635-9. PubMed ID: 4098545
[No Abstract] [Full Text] [Related]
20. [Use of an oral contraceptive Femigen-Polfa by epileptic women].
Rościszewska D
Neurol Neurochir Pol; 1973; 7(5):715-7. PubMed ID: 4128492
[No Abstract] [Full Text] [Related]
[Next] [New Search]
